Omeq Medical is rated 3 out of 5 in the category medical devices. Read and write reviews about Omeq Medical. Omeq Medical is an Israel-based Medical Device Start-Up, developing a sensor-based epidural placement system for quicker, safer and more accurate epidural injections, taking over a $600 million global market. Founded in April 2013, Omeq Medical closed its first investment round with Israel‘s leading seed stage investor The Trendlines Group and is currently raising funds for the next investment round. Drugs injected into the epidural space (“epidurals”) are used for anesthesia and analgesic purposes during childbirth and surgery. Locating the epidural space requires careful insertion and advancement of a needle into the middle or lower back. Inaccurate needle placement occurs in up to 30% of cases, resulting in ineffective drug delivery and complications such as severe headaches or nerve damage. Omeq Medical's sensor-based epidural placement device will assist physicians in performing safe and accurate epidural injections by giving audio and visual feedback. The Advantages • Real-time, objective detection of the epidural space • Improved analgesia/anesthesia success rate • Reduced needle placement complications • Less time needed per procedure • Used in conjunction with the Loss of Resistence technique The Team - Lior Margalit, CEO - Oded Tsamir, VP R&D - Daniel Levin, Ph.D., Business Advisor - Prof. Elon Eisenberg, Medical Advisor - David Gichtin, M.D., Medical Advisor
Company size
1-10 employees
Headquarters
Misgav Industrial Park